Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PAZOPANIB Cause Blood creatinine increased? 152 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Blood creatinine increased have been filed in association with PAZOPANIB (Pazopanib). This represents 0.7% of all adverse event reports for PAZOPANIB.

152
Reports of Blood creatinine increased with PAZOPANIB
0.7%
of all PAZOPANIB reports
24
Deaths
59
Hospitalizations

How Dangerous Is Blood creatinine increased From PAZOPANIB?

Of the 152 reports, 24 (15.8%) resulted in death, 59 (38.8%) required hospitalization, and 7 (4.6%) were considered life-threatening.

Is Blood creatinine increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 152 reports have been filed with the FAERS database.

What Other Side Effects Does PAZOPANIB Cause?

Death (3,767) Diarrhoea (2,907) Fatigue (1,883) Nausea (1,879) Malignant neoplasm progression (1,471) Drug ineffective (1,135) Decreased appetite (1,116) Vomiting (1,072) Hypertension (1,004) Malaise (764)

What Other Drugs Cause Blood creatinine increased?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,966) TENOFOVIR DISOPROXIL (1,460) TACROLIMUS (1,439) METHOTREXATE (1,401) SACUBITRIL\VALSARTAN (1,389) RITUXIMAB (1,265) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,112) METFORMIN (986) ECULIZUMAB (967) LENALIDOMIDE (959)

Which PAZOPANIB Alternatives Have Lower Blood creatinine increased Risk?

PAZOPANIB vs PEANUT PAZOPANIB vs PEG INTERFERON PAZOPANIB vs PEG-INTERFERON ALFA 2A PAZOPANIB vs PEGASPARGASE PAZOPANIB vs PEGASYS

Related Pages

PAZOPANIB Full Profile All Blood creatinine increased Reports All Drugs Causing Blood creatinine increased PAZOPANIB Demographics